Hyperbaric ropivacaine comparison with hyperbaric bupivacaine in spinal anaesthesia in transurethral resection of prostate
Not Applicable
Completed
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/06/043065
- Lead Sponsor
- Government Institute Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. Adult patients aged between 55-80 years,
2. American Society of Anesthesiologists (ASA) grade1 and grade2
3. Scheduled for elective surgery under spinal anesthesia
4. No history of allergy or sensitivity to any of the studied local anesthetics.
Exclusion Criteria
1.Patients have significant cardiovascular disease, Hypertension, renal failure, hepatic dysfunction, and chronic pulmonary disease.
2. Neuromuscular disorder
3. Morbid obesity
4. Bleeding disorders
5. Infection at the local site
6. Any patient on prolonged drug therapy
7. Uncooperative patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of clinical efficacy of hyperbaric ropivacaine with hyperbaric bupivacaine in spinal anaesthesiaTimepoint: To compare the efficacy in terms of hemodynamic stability & duration of motor block until return to normal function
- Secondary Outcome Measures
Name Time Method 1The total duration of sensory blockade <br/ ><br>2Total duration of analgesiaTimepoint: <br/ ><br>1 The total duration of sensory blockade will be defined as the time interval between spinal anesthesia till block regression to S2 segment. <br/ ><br> <br/ ><br>2 Duration of analgesia will be defined as time interval from subarachnoid injection to the point where patients demanded rescue analgesics for pain relief and3. any adverse effects. <br/ ><br>